Avidity Biosciences Executives Sell Shares at $72.45/Share on 2026-01-21

Avidity Biosciences, Inc. has announced the sale of shares by several key executives. The company's Director, President and CEO, Sarah Boyce, sold 7,993 shares at $72.45 per share on January 21, 2026. Chief Scientific Officer Michael Flanagan sold 3,976 shares at the same price on the same day, while Chief Medical Officer Steven George Hughes sold 2,017 shares. Director Arthur Levin sold 1,758 shares and Chief Financial Officer Michael MacLean sold 2,735 shares at the same price. Chief Human Resources Officer Teresa McCarthy sold 1,453 shares and 1,476 shares on January 21, 2026.